Table 1.

G1 Exit in the Presence of Nocodazole

G1 Exit
LXSN AS21
% G1% Decrease % G1 % Decrease
24 Hours  
 Untreated 65 ± 5  −  61 ± 3  −  
 Low NOC  64 ± 8  1.5  54 ± 6  11.5  
 High NOC 76 ± 6  −17.0* 60 ± 7  1.6  
48 Hours 
 Untreated  70 ± 4  −  56 ± 4 −  
 Low NOC  44 ± 7  37.1* 14 ± 2 75.0* 
 High NOC  65 ± 11  7.1  26 ± 3 53.6* 
G1 Exit
LXSN AS21
% G1% Decrease % G1 % Decrease
24 Hours  
 Untreated 65 ± 5  −  61 ± 3  −  
 Low NOC  64 ± 8  1.5  54 ± 6  11.5  
 High NOC 76 ± 6  −17.0* 60 ± 7  1.6  
48 Hours 
 Untreated  70 ± 4  −  56 ± 4 −  
 Low NOC  44 ± 7  37.1* 14 ± 2 75.0* 
 High NOC  65 ± 11  7.1  26 ± 3 53.6* 

G1 exit was calculated from cell cycle analysis data by determining the percentage decrease of the G0/G1 proportion of nocodazole-treated cultures compared with untreated control cultures. This reflects the proportion of cells that could progress from G0/G1 phase and enter S and G2/M phases and was used as a measure of the G0/G1 phase arresting effects of nocodazole. Data are the mean ± SD from three experiments.

*

Statistically different from untreated control (LXSN), P < .05.

Close Modal

or Create an Account

Close Modal
Close Modal